ABC’s of Hepatitis: PSSNY AlbanyMed Conference
At the completion of the activity viewers will be able to:
Describe the transmission and presentation of Hepatitis viruses
State the importance of screening for hepatitis B and C
Describe the work-up of patients living with hepatitis B and C
Recognize the principles and goals of antiviral therapy for hepatitis B and C
Kristen Marks, MD
Dr. Marks is an Associate Professor of Medicine at Weill Cornell Medicine (WCM) where she conducts clinical trials related to HIV, HCV and COVID prevention and treatment. She received Internal Medicine residency and Infectious Diseases fellowship training at New York-Presbyterian Hospital (Cornell), where she focused clinical training and research on HIV and hepatitis virus infections and completed Weill Cornell's Master's Degree in Clinical Investigation.
She serves as a co-director of the Cornell HIV/AIDS Clinical Trials Unit, where she conducts several treatment studies related to HIV and hepatitis viruses. She served as co-chair of IDSA/AASLD’s joint guidelines panel for “Recommendations for testing, managing and treating hepatitis C” and as a member of New York State’s HCV guidelines panel. When the COVID pandemic hit New York City, she led the phase 3 studies of remdesivir at Weill Cornell and continues to lead the phase 3 studies of vaccines for the prevention of COVID at Weill Cornell. Dr. Marks has served as research mentor to both trainees and junior faculty, through this work on two divisional mentorship committees, she has fostered the career development of fellows and junior faculty.
ACPE UAN #
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.